Possible Allogeneic Graft-Versus-Tumor Effect in Childhood Melanoma

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 12, 2003, Pages 982-986

  Kasow, Kimberly A ^a   Handgretinger, Rupert ^a   Krasin, Matthew J ^a   Pappo, Alberto S ^b   Leung, Wing ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Graft versus tumor effect; Hematopoietic stem cell transplantation; Melanoma

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; CYCLOSPORIN; DACARBAZINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; VINBLASTINE;

ADOLESCENT; ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER SURVIVAL; CASE REPORT; CHILDHOOD CANCER; DISEASE COURSE; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MELANOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ADOLESCENT; BRAIN NEOPLASMS; FATAL OUTCOME; FEMALE; GRAFT SURVIVAL; GRAFT VS TUMOR EFFECT; HUMANS; MELANOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0347383978     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200312000-00016     Document Type: Article

References (10)

1. Pappo AS. Childhood melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds. Cutaneous Melanoma, 3d ed. St. Louis, Missouri: Quality Medical Publishers, 1998:175-186.
2. Nathan PD, Eisen TG. The biological treatment of renal-cell carcinoma and melanoma. Lancet Oncol. 2002;3:89-96.
3. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411:380-384.
4. Childs R, Chemoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 2000;343:750-758.
5. Bay JO, Choufi B, Pomel C, et al. Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer. Bone Marrow Transplant. 2000; 25:681-682.
6. Ueno NT, Rondon G, Mirza NQ, et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol. 1998;16:986-993.
7. Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature. 2001;411:385-389.
8. Kurokawa T, Fischer K, Bertz H, et al. In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation. Int J Cancer. 2002;101:52-60.
9. Pedrazzoli P, Da Prada GA, Giorgiani G, et al. Allogeneic blood stem cell transplantation after a reduced-intensity preparative regimen: a pilot study in patients with refractory malignancies. Cancer. 2002;94:2409-2415.
10. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol. 2002;3:999-1005.